Background & Aims: Risk factors of metachronous liver metastases and death are not well
known in patients with the Zollinger–Ellison syndrome and multiple endocrine neoplasia …

Background/Aims: It is unclear whether tumor location, size, or the presence of multiple
endocrine neoplasia type 1 (MEN-1) alters metastatic rate and survival in patients with …

Mignon M, Cadiot G (Bichat and Claude Bernard Hospital, Paris, France). Diagnostic and
therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine …

PURPOSE: The long-term clinical course of unselected patients with gastrinomas as well as
other functional pancreatic endocrine tumors (PETs) in whom the excess-hormone state is …

The clinical evolution of type I multiple endocrine neoplasia (MEN I) was studied in 45
patients among a consecutive series of 172 with Zollinger-Ellison syndrome (ZES). These …

Objective To determine the role of surgery in patients with Zollinger-Ellison syndrome (ZES)
and multiple endocrine neoplasia type 1 (MEN1) with either limited or advanced pancreatic …

Objective: The authors assessed the impact of gastrinoma resection on the subsequent
development of hepatic metastases in Zollinger-Ellison syndrome. Summary Background …

Background. The long-term prognosis of Zollinger-Ellison Syndrome (ZES) is not well
defined. The findings of other endocrinopathies, the need for long-term surveillance, and the …

Background and Methods The role of surgery in patients with the Zollinger–Ellison
syndrome is controversial. To determine the efficacy of surgery in patients with this …

Pancreaticoduodenal tumors develop in a majority of patients with multiple endocrine
neoplasia type 1 (MEN 1) and have a pronounced effect on life expectancy as the principal …